John Hancock Variable Insurance Trust - Health Sciences Trust (JAFKX)
| Fund Assets | n/a |
| Expense Ratio | 1.24% |
| Min. Investment | $0.00 |
| Turnover | n/a |
| Dividend (ttm) | 3.23 |
| Dividend Yield | 15.46% |
| Dividend Growth | 89.39% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Oct 23, 2025 |
| Previous Close | 20.92 |
| YTD Return | 11.76% |
| 1-Year Return | 11.76% |
| 5-Year Return | n/a |
| 52-Week Low | 17.17 |
| 52-Week High | 21.17 |
| Beta (5Y) | n/a |
| Holdings | 175 |
| Inception Date | n/a |
About JAFKX
John Hancock Variable Insurance Trust Health Sciences Trust Series II is an investment fund designed primarily for use within variable insurance products. Its central purpose is to provide investors with exposure to the healthcare and life sciences sectors by investing in equity securities of companies involved in health sciences, including pharmaceuticals, biotechnology, healthcare equipment, and services. The fund targets companies with durable and niche business models that are positioned to deliver high returns on capital, often focusing on mid- to large-cap firms with established market capitalizations and strong growth prospects. Employing a bottom-up stock selection approach, the fund's management emphasizes fundamental analysis to identify undervalued opportunities within the sector. Its role in the financial market is to offer diversification for investors seeking concentrated healthcare exposure within the broader context of insurance-linked investments, helping balance portfolio risk while capitalizing on innovation and demographic trends driving the health sciences industry. The fund is actively managed and reflects John Hancock’s commitment to sector-specific investment strategies within variable insurance trusts.
Performance
JAFKX had a total return of 11.76% in the past year, including dividends. Since the fund's inception, the average annual return has been 2.58%.
Top 10 Holdings
39.95% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company - ELI LILLY and CO COMMON STOCK | LLY.US | 10.20% |
| Thermo Fisher Scientific Inc. - THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0 | TMO.US | 4.12% |
| Intuitive Surgical Inc. - INTUITIVE SURGICAL INC COMMON STOCK USD.001 | ISRG.US | 3.71% |
| Stryker Corporation - STRYKER CORP COMMON STOCK USD.1 | SYK.US | 3.52% |
| Merck and Co. Inc. - MERCK and CO INC COMMON STOCK USD.5 | MRK.US | 3.48% |
| ASTRAZENECA PLC COMMON STOCK USD.25 | AZN.US | 3.22% |
| UnitedHealth Group Incorporated - UNITEDHEALTH GROUP INC COMMON STOCK USD.01 | UNH.US | 3.13% |
| ARGENX SE ADR | ARGX.US | 2.99% |
| AbbVie Inc. - ABBVIE INC COMMON STOCK USD.01 | ABBV.US | 2.88% |
| Regeneron Pharmaceuticals Inc. - REGENERON PHARMACEUTICALS INC COMMON STOCK USD.001 | REGN.US | 2.69% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Oct 23, 2025 | $3.23399 | Oct 24, 2025 |
| Oct 24, 2024 | $1.70757 | Oct 25, 2024 |
| Oct 24, 2023 | $1.26206 | Oct 25, 2023 |
| Oct 25, 2022 | $3.23984 | Oct 26, 2022 |